Wright Medical (NSDQ:WMGI) today said it raised $395 million in a private placement of debt with a syndicate of institutional investors. The offering, of 2.25% convertible senior notes due in 2021, is expected to close May 20, Wright said. Some holders of Wright’s 2.0% notes due in 2017 and 2020 have pledged to exchange the […]
Funding Roundup
Teleflex prices $400m debt offering
Teleflex (NYSE:TFX) yesterday priced $400 million worth of debt that the maker of surgical tools and equipment plans to use for debt refinancing. The offering, of 4.875% senior notes due in 2026, is expected to close May 16. Teleflex said it plans call to use the money to refinance $393 million in debt under its revolving credit facility. J.P. Morgan and BofA Merrill […]
EndoStim raises $25m Series D for neurostim GERD device
Five months after spiking its plans for an initial public offering, EndoStim said today that it raised a $25 million Series D round for the neurostimulation device it’s developing to treat gastroesophageal reflux disease. Saint Louis- and Nijmegen, Holland-based EndoStim said Endeavour Vision led the round, joined by existing backer Santé Ventures and new investors Wellington Partners and Gimv. Endostim […]
Intarcia raises another $75m, touts top-line safety data in pivotal trial
Intarcia Therapeutics said today that it raised another $75 million in a debt financing round and touted the top-line cardiovascular safety data from the final phase in its clinical program for its ITCA 650 implantable drug pump for Type II diabetics. Boston-based Intarcia said it plans to begin filing for U.S. approval from the FDA during the 3rd […]
Baxter boosts Baxalta share exchange offer
Baxter (NYSE:BAX) said today that its raising the size of its offer to exchange its own shares for those of its Baxalta (NYSE: BXLT) pharmaceuticals spinout ahead of its acquisition by Shire (NSDQ:SHPGY). Baxter cut its stake in Baxalta in January from 19.4% to 13.8%. In March, Deerfield, Ill.-based Baxter exchanged about 59.4 million Baxalta shares at $39.40 apiece, leave […]
MVM Life Science Partners closes $233m healthcare fund
MVM Life Science Partners said it plans to use the $233 million it raised for its 4th fund to invest in medical companies in the U.S. and Europe. The Boston-and-London-based investment shop said the fund is its largest so far. MVM said it backs public and private companies at every stage of development, with investments of between […]
Pavmed IPO grosses $5.3m
Updated with the correct stock ticker for currently trading Pavmed units (PAVMU) Pavmed said today that its initial public offering grossed $5.3 million, after extending the flotation last month for an extra 45 days. Pavmed is developing devices in 5 areas, according to its IPO registration: The PortIO long-term implantable vascular access device; the Caldus line […]
Chinese mobile Internet firm Liaison Interactive puts $20m into Dehaier Medical
Dehaier Medical Systems (NSDQ:DHRM) said today that a Chinese mobile Internet firm, Hangzhou Liaison Interactive Information Technology (SHE:002280), took out a $20 million stake. The $1.80-per-share deal is a 35% premium on Dehaier’s $1.33 closing price yesterday. It includes warrants for 1 million shares exercisable at $2.20 apiece and is expected to close by June 30, Dehaier […]
Philips says IPO likely for legacy lighting biz
Royal Philips (NYSE:PHG) said today that it’s likely to float an initial public offering for its legacy lighting business, which would create the world’s largest stand-alone light maker. Philips, which launched in 1891, is partly through a plan to pare its businesses to better focus on its merged healthcare and consumer businesses. CEO Frans van Houten […]
Viveve preps $12m offering ahead of NASDAQ uplisting
Viveve (OTC:VIVMD) said today that it’s planning to raise $11.5 million, having executed a 1-for-8 reverse stock split, as part of its uplisting from the over-the-counter exchange to the NASDAQ board. Sunnyvale, Calif.-based Viveve makes a non-surgical treatment for post-partum laxity of the vaginal introitus. The company put the reverse split into place yesterday; today Viveve said it plans to hit […]
Helius Medical raises $7m for portable neuromodulation stimulator
Helius Medical Technologies (OTC:HSDT) said today that it raised $7.2 million (C$9.2 million) in a Canadian short-form offering and a concurrent private placement in the U.S. Newtown, Pa.-based Helius said each unit of the offering had a Class A share and a half-share warrant with an exercise price of roughly $1.17 (C$1.50). The company also said it got […]